193 related articles for article (PubMed ID: 29250205)
1. Next generation sequencing: clinical applications in solid tumours.
Müllauer L
Memo; 2017; 10(4):244-247. PubMed ID: 29250205
[TBL] [Abstract][Full Text] [Related]
2. Integration of Liquid Biopsies into Clinical Laboratory Applications via NGS in Cancer Diagnostics.
Sonmezler O; Boga I; Bisgin A
Clin Lab; 2020 May; 66(5):. PubMed ID: 32390404
[TBL] [Abstract][Full Text] [Related]
3. Development, Implementation and Assessment of Molecular Diagnostics by Next Generation Sequencing in Personalized Treatment of Cancer: Experience of a Public Reference Healthcare Hospital.
Simarro J; Murria R; Pérez-Simó G; Llop M; Mancheño N; Ramos D; Juan I; Barragán E; Laiz B; Cases E; Ansótegui E; Gómez-Codina J; Aparicio J; Salvador C; Juan Ó; Palanca S
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31426418
[TBL] [Abstract][Full Text] [Related]
4. Molecular tests and target therapies in oncology: recommendations from the Italian workshop.
Pinto C; Biffoni M; Popoli P; Marchetti A; Marchetti P; Martini N; Normanno N
Future Oncol; 2021 Sep; 17(26):3529-3539. PubMed ID: 34254524
[TBL] [Abstract][Full Text] [Related]
5. High concordance of actionable genomic alterations identified between circulating tumor DNA-based and tissue-based next-generation sequencing testing in advanced non-small cell lung cancer: The Korean Lung Liquid Versus Invasive Biopsy Program.
Park S; Olsen S; Ku BM; Lee MS; Jung HA; Sun JM; Lee SH; Ahn JS; Park K; Choi YL; Ahn MJ
Cancer; 2021 Aug; 127(16):3019-3028. PubMed ID: 33826761
[TBL] [Abstract][Full Text] [Related]
6. Next Generation Sequencing (NGS): A Revolutionary Technology in Pharmacogenomics and Personalized Medicine in Cancer.
Morganti S; Tarantino P; Ferraro E; D'Amico P; Duso BA; Curigliano G
Adv Exp Med Biol; 2019; 1168():9-30. PubMed ID: 31713162
[TBL] [Abstract][Full Text] [Related]
7. Implementation of Next Generation Sequencing-Based Liquid Biopsy for Clinical Molecular Diagnostics in Non-Small Cell Lung Cancer (NSCLC) Patients.
Zulato E; Tosello V; Nardo G; Bonanno L; Del Bianco P; Indraccolo S
Diagnostics (Basel); 2021 Aug; 11(8):. PubMed ID: 34441402
[TBL] [Abstract][Full Text] [Related]
8. Next-Generation sequencing transforming clinical practice and precision medicine.
Yadav D; Patil-Takbhate B; Khandagale A; Bhawalkar J; Tripathy S; Khopkar-Kale P
Clin Chim Acta; 2023 Nov; 551():117568. PubMed ID: 37839516
[TBL] [Abstract][Full Text] [Related]
9. Roadbook for the implementation of next-generation sequencing in clinical practice in oncology and hemato-oncology in Belgium.
Van Valckenborgh E; Hébrant A; Antoniou A; Van Hoof W; Van Bussel J; Pauwels P; Salgado R; Van Doren W; Waeytens A; Van den Bulcke M
Arch Public Health; 2018; 76():49. PubMed ID: 30202522
[TBL] [Abstract][Full Text] [Related]
10. Recent advance of next-generation sequencing in patients with lung cancer.
Qiu T; Zhi X; Ren S
Expert Rev Mol Diagn; 2023; 23(11):959-970. PubMed ID: 37750512
[TBL] [Abstract][Full Text] [Related]
11. Complexity of genome sequencing and reporting: Next generation sequencing (NGS) technologies and implementation of precision medicine in real life.
Morganti S; Tarantino P; Ferraro E; D'Amico P; Viale G; Trapani D; Duso BA; Curigliano G
Crit Rev Oncol Hematol; 2019 Jan; 133():171-182. PubMed ID: 30661654
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas9 and next generation sequencing in the personalized treatment of Cancer.
Selvakumar SC; Preethi KA; Ross K; Tusubira D; Khan MWA; Mani P; Rao TN; Sekar D
Mol Cancer; 2022 Mar; 21(1):83. PubMed ID: 35331236
[TBL] [Abstract][Full Text] [Related]
13. Next-generation sequencing in routine brain tumor diagnostics enables an integrated diagnosis and identifies actionable targets.
Sahm F; Schrimpf D; Jones DT; Meyer J; Kratz A; Reuss D; Capper D; Koelsche C; Korshunov A; Wiestler B; Buchhalter I; Milde T; Selt F; Sturm D; Kool M; Hummel M; Bewerunge-Hudler M; Mawrin C; Schüller U; Jungk C; Wick A; Witt O; Platten M; Herold-Mende C; Unterberg A; Pfister SM; Wick W; von Deimling A
Acta Neuropathol; 2016 Jun; 131(6):903-10. PubMed ID: 26671409
[TBL] [Abstract][Full Text] [Related]
14. Comparative analysis of genomic profiles between tissue-based and plasma-based next-generation sequencing in patients with non-small cell lung cancer.
Lin Z; Li Y; Tang S; Deng Q; Jiang J; Zhou C
Lung Cancer; 2023 Aug; 182():107282. PubMed ID: 37392713
[TBL] [Abstract][Full Text] [Related]
15. [Genome sequencing and personalized medicine: perspectives and limitations].
Le Gall JY; Debré P;
Bull Acad Natl Med; 2014 Jan; 198(1):101-17. PubMed ID: 26259290
[TBL] [Abstract][Full Text] [Related]
16. Liquid Biopsy, ctDNA Diagnosis through NGS.
Lin C; Liu X; Zheng B; Ke R; Tzeng CM
Life (Basel); 2021 Aug; 11(9):. PubMed ID: 34575039
[TBL] [Abstract][Full Text] [Related]
17. The use of next-generation sequencing in personalized medicine.
Popova L; Carabetta VJ
ArXiv; 2024 Mar; ():. PubMed ID: 38495572
[TBL] [Abstract][Full Text] [Related]
18. Clinical applicability and cost of a 46-gene panel for genomic analysis of solid tumours: Retrospective validation and prospective audit in the UK National Health Service.
Hamblin A; Wordsworth S; Fermont JM; Page S; Kaur K; Camps C; Kaisaki P; Gupta A; Talbot D; Middleton M; Henderson S; Cutts A; Vavoulis DV; Housby N; Tomlinson I; Taylor JC; Schuh A
PLoS Med; 2017 Feb; 14(2):e1002230. PubMed ID: 28196074
[TBL] [Abstract][Full Text] [Related]
19. Next generation sequencing in clinical medicine: Challenges and lessons for pathology and biomedical informatics.
Gullapalli RR; Desai KV; Santana-Santos L; Kant JA; Becich MJ
J Pathol Inform; 2012; 3():40. PubMed ID: 23248761
[TBL] [Abstract][Full Text] [Related]
20. Routine application of next-generation sequencing testing in uro-oncology-Are we ready for the next step of personalised medicine?
Rodler S; Jung A; Greif PA; Rühlmann K; Apfelbeck M; Tamalunas A; Kretschmer A; Schulz GB; Szabados B; Stief C; Heinemann V; Westphalen CB; Casuscelli J
Eur J Cancer; 2021 Mar; 146():1-10. PubMed ID: 33535139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
